Congresswoman to speak at benefit gala for cancer research
Congresswoman Rosa DeLauro (D-CT) is scheduled to be a featured speaker at the second Yale Discovery to Cure Gala Benefit to raise support for and awareness about reproductive cancers in women, to be held Saturday, June 11, at 6 p.m. at Branford College, 74 High St.
"Discovery to Cure: Advancing Prevention, Early Detection and Treatment of Women's Reproductive Cancers" is a program of Yale Gynecologic Oncology, a section of the Department of Obstetrics, Gynecology and Reproductive Sciences, with a focus on early detection, care and treatment, and the development of novel therapies for ovarian and other gynecologic cancers.
The gala committee members, including Connecticut Governor Jodi Rell and DeLauro, are dedicated to raising support and consciousness for Yale's efforts to identify women's reproductive cancers in their earliest stages and to pioneer therapeutic strategies for the prevention and treatment of these diseases. Over 350 people are expected to attend the event.
In addition to the dinner, the evening will include a brief presentation on the Discovery to Cure program, a silent auction, music by Yale students and a souvenir journal. Tickets for tables are $10,000, $5,000 and $2,500, with individual tickets at $250 each.
Yale physicians and scientists have helped to advance the practice of modern medicine by pioneering viable new treatments for cancer patients currently in use today -- from the creation of an early detection program for ovarian cancer in 1990 to the development of the latest drug to enhance combination chemotherapy for ovarian cancer patients whose cancer cells have become resistant to chemotherapy. Researchers in the Section of Gynecologic Oncology at Yale recently developed a new blood test to distinguish healthy women from those with ovarian cancer, based on the levels of key proteins in the blood.
A major challenge with ovarian cancer is that three-quarters of patients with the disease do not display significant symptoms until it has spread to other parts of the body. The early detection component of Discovery to Cure seeks to screen women at greatest risk for developing ovarian and other gynecologic cancers.
The Discovery to Cure program is also a site for the development of the latest clinical trials and new treatments for ovarian cancer patients. For information about the Discovery to Cure Gala, contact Chris Pates at (203) 785-4761 or by e-mail at christopher.pates@yale.edu.
T H I SW E E K ' SS T O R I E S
Yale committed to offering overseas opportunities to all undergraduates
COMMENCEMENT 2005
|